Title page
Type of the study: Case report
Title: Tyrosine kinase inhibitor-induced severe bullous pemphigoid in a patient with advanced stage of liver cancer: a case report and literature review
Authors: Li Y1,2, Wang M1,2, Wang TT1,2*
1Author affiliations Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, China
2Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China
* Correspondence: Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, China. Email: wangtingting817@126.com
Ethics statement: All appropriate informed consent forms were obtained from the patient’s parent. The patient’s parent gave written informed consent for publication of the report details and associated photographs. Institutional approval was not required to publish the case details.
Conflict of interest: None.
Financial support: None.
Author contributions: LY and WTT designed the study and acquired, analyzed, and interpreted the data. LY wrote the manuscript. WTT and WM critically revised the manuscript for important intellectual content. All authors have contributed to the manuscript and approved the submitted version.
Tyrosine kinase inhibitor-induced severe bullous pemphigoid in a patient with advanced stage of liver cancer: a case report and literature review
Yu Li1, Mi Wang1,2, Tingting Wang1,2
1Author affiliations Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, China
2Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China
Correspondence: Tingting Wang
Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, China. Email: wangtingting817@126.com